325 related articles for article (PubMed ID: 16540456)
21. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
22. Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive multifocal leukoencephalopathy.
D'Amico R; Sarkar S; Yusuff J; Azar E; Perlman DC
Scand J Infect Dis; 2007; 39(4):347-50. PubMed ID: 17454900
[TBL] [Abstract][Full Text] [Related]
23. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
Kishida S
No To Shinkei; 2007 Feb; 59(2):125-37. PubMed ID: 17315754
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory progressive multifocal leukoencephalopathy after antiretroviral treatment.
Silva MT; Pacheco MC; Vaz B
AIDS; 2006 Feb; 20(3):469-71. PubMed ID: 16439887
[No Abstract] [Full Text] [Related]
25. Evolution of purely infratentorial PML under HAART--negative outcome under rapid immune reconstitution.
Kastrup O; Wanke I; Esser S; Maschke M
Clin Neurol Neurosurg; 2005 Oct; 107(6):509-13. PubMed ID: 16202824
[TBL] [Abstract][Full Text] [Related]
26. [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy].
Imamura E; Yamashita H; Fukuhara T; Sawa H; Nagashima K; Kuwabara M; Tokinobu H
Rinsho Shinkeigaku; 2007 Oct; 47(10):650-6. PubMed ID: 18095498
[TBL] [Abstract][Full Text] [Related]
27. [Progressive multifocal leukoencephalopathy: virological and neuropathological aspects].
Ingrand D; Gray F
Arch Anat Cytol Pathol; 1997; 45(2-3):127-34. PubMed ID: 9382604
[TBL] [Abstract][Full Text] [Related]
28. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
[TBL] [Abstract][Full Text] [Related]
29. Review of progressive multifocal leukoencephalopathy and natalizumab.
Aksamit AJ
Neurologist; 2006 Nov; 12(6):293-8. PubMed ID: 17122725
[TBL] [Abstract][Full Text] [Related]
30. Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: impact versus resources in Brazil.
Silva MT; Araújo A
J Neurovirol; 2005; 11 Suppl 3():11-5. PubMed ID: 16540448
[TBL] [Abstract][Full Text] [Related]
31. [Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].
Arendt G
Fortschr Neurol Psychiatr; 2005 Oct; 73(10):577-86. PubMed ID: 16217698
[TBL] [Abstract][Full Text] [Related]
32. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment.
Gray F; Bazille C; Adle-Biassette H; Mikol J; Moulignier A; Scaravilli F
J Neurovirol; 2005; 11 Suppl 3():16-22. PubMed ID: 16540449
[TBL] [Abstract][Full Text] [Related]
33. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?
Koralnik IJ
Ann Neurol; 2006 Aug; 60(2):162-73. PubMed ID: 16862584
[TBL] [Abstract][Full Text] [Related]
34. Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy.
Razonable RR; Aksamit AJ; Wright AJ; Wilson JW
Mayo Clin Proc; 2001 Nov; 76(11):1171-5. PubMed ID: 11702907
[TBL] [Abstract][Full Text] [Related]
35. Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions.
Stüve O; Marra CM; Cravens PD; Singh MP; Hu W; Lovett-Racke A; Monson NL; Phillips JT; Tervaert JW; Nash RA; Hartung HP; Kieseier BC; Racke MM; Frohman EM; Hemmer B
Arch Neurol; 2007 Feb; 64(2):169-76. PubMed ID: 17296831
[TBL] [Abstract][Full Text] [Related]
36. [The neuropathology of HIV infection in the era of highly active antiretroviral therapy].
Vallat-Decouvelaere AV; Chrétien F; Lorin de la Grandmaison G; Carlier R; Force G; Gray F
Ann Pathol; 2003 Oct; 23(5):408-23. PubMed ID: 14752384
[TBL] [Abstract][Full Text] [Related]
37. HIV-associated central nervous system diseases in the era of combination antiretroviral therapy.
Tan IL; McArthur JC
Eur J Neurol; 2011 Mar; 18(3):371-2. PubMed ID: 21159069
[No Abstract] [Full Text] [Related]
38. [Neuropathology of progressive multifocal leukoencephalopathy].
Murayama S; Saito Y
Brain Nerve; 2007 Feb; 59(2):119-24. PubMed ID: 17380776
[TBL] [Abstract][Full Text] [Related]
39. Images in HIV/AIDS. Fatal progressive multifocal leukoencephalopathy: still a problem in the era of highly active antiretroviral therapy.
Cole J; Aboulafia DM
AIDS Read; 2009 Mar; 19(3):110-2. PubMed ID: 19334327
[No Abstract] [Full Text] [Related]
40. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.
Berenguer J; Miralles P; Arrizabalaga J; Ribera E; Dronda F; Baraia-Etxaburu J; Domingo P; Márquez M; Rodriguez-Arrondo FJ; Laguna F; Rubio R; Lacruz Rodrigo J; Mallolas J; de Miguel V;
Clin Infect Dis; 2003 Apr; 36(8):1047-52. PubMed ID: 12684918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
